Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Surgery Partners (SGRY) Leases (2016 - 2025)

Surgery Partners (SGRY) has disclosed Leases for 12 consecutive years, with $944.5 million as the latest value for Q4 2025.

  • Quarterly Leases rose 15.45% to $944.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $944.5 million through Dec 2025, up 15.45% year-over-year, with the annual reading at $944.5 million for FY2025, 15.45% up from the prior year.
  • Leases hit $944.5 million in Q4 2025 for Surgery Partners, up from $747.5 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $944.5 million in Q4 2025 to a low of $305.4 million in Q1 2021.
  • Historically, Leases has averaged $561.5 million across 5 years, with a median of $579.4 million in 2023.
  • Biggest five-year swings in Leases: skyrocketed 91.54% in 2022 and later fell 7.02% in 2023.
  • Year by year, Leases stood at $329.6 million in 2021, then surged by 91.54% to $631.3 million in 2022, then dropped by 7.02% to $587.0 million in 2023, then surged by 39.37% to $818.1 million in 2024, then increased by 15.45% to $944.5 million in 2025.
  • Business Quant data shows Leases for SGRY at $944.5 million in Q4 2025, $747.5 million in Q3 2025, and $751.9 million in Q2 2025.